SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to Section 240.14a-12
Benessere Capital Acquisition Corp.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
Benessere Capital Acquisition Corp. Reminds Stockholders of Special Meeting on July 7, 2022 and Extends Redemption Date
NEW YORK, July 6, 2022 /PRNewswire/ Benessere Capital Acquisition Corp. (Nasdaq: BENE, BENEU, BENEW, and BENER) (Benessere or the Company) encourages its stockholders to vote in favor of the proposal to amend its charter (the Extension Amendment) to extend the date by which the Company has to complete a business combination from July 7, 2022 to January 7, 2023, or such earlier date as determined by the Board (the Extended Date) (the Extension).
A special meeting of the Companys stockholders (Special Meeting) to approve the Extension Amendment will be held virtually on July 7, 2022 at 12:00 PM, Eastern Time and can be accessed by visiting https://www.cstproxy.com/benespac/sm2022.
The Companys stockholders of record at the close of business on the record date, June 3, 2022, are entitled to vote the shares of common stock of Benessere owned by them at the Special Meeting. Every stockholders vote is important, regardless of the number of shares held, and the Company requests the prompt submission of votes. Stockholders of record may vote online at the Special Meeting or by submitting a proxy for the Special Meeting.
If stockholders have any questions or need assistance in identifying the 12-digit meeting control number or any other matter please call the Companys proxy solicitor, Advantage Proxy, at 1-877-870-8565 (toll free) or by email at firstname.lastname@example.org.
In view of the upcoming Special Meeting date, the Company has extended the deadline for holders of the Companys Class A common stock issued in the Companys initial public offering to submit their shares for redemption in connection with the Extension Amendment to 5:00 p.m. Eastern Time on Wednesday, July 6, 2022.
If the Extension Amendment is approved and the Extension is implemented, the Companys sponsor will contribute to the Companys trust account an aggregate amount equal to $0.033 per share of Class A common stock issued in the Companys initial public offering that is not redeemed in connection with the stockholder vote to approve the Extension Amendment, for each calendar month (commencing on July 7, 2022 and on the 7th day of each subsequent month) until the Extended Date, or portion thereof. Such contributions will be made as a loan that will not accrue interest and will be repayable to the sponsor or its designee upon the consummation of an initial business combination. The Contribution will increase the pro rata portion of the funds available in the Companys trust account in the event of the consummation of an initial business combination or liquidation from approximately $10.35 per share to up to approximately $10.55 per share.
Benessere is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Benesseres strategy is to identify and complete business combinations with technology-focused middle market and emerging growth companies in North, Central and South America. For more information, please visit www.benespac.com.
Forward Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Companys expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.